|
Volumn 369, Issue 8, 2013, Pages 782-783
|
Respiratory syncytial virus and recurrent wheeze
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PALIVIZUMAB;
PLACEBO;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE COST;
HOSPITALIZATION;
HUMAN;
INFECTION PREVENTION;
LETTER;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RESPIRATORY SYNCYTIAL VIRUS INFECTION;
RISK FACTOR;
WHEEZING;
HOSPITAL ADMISSION;
HOSPITAL COST;
QUALITY OF LIFE;
VIRAL BRONCHIOLITIS;
|
EID: 84882787181
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1307429 Document Type: Letter |
Times cited : (21)
|
References (1)
|